Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Reem Capital Corp. (TSXV: REEM.P) ("Reem" or the "Corporation"), a "capital pool company" pursuant to the policies of the TSX Venture Exchange ...

The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and is projected to ...

Global Pulmonary Arterial Hypertension (PAH) Treatment Market is thriving due to a rising prevalence of pulmonary hypertension, advancements in drug development, increasing awareness about the disease ...

The proposed duties—linked to India’s high tariffs, non-tariff barriers, and Russia ties—could disrupt key sectors like ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Teva's transformation boosts profit growth and specialty drugs, offering an undervalued opportunity. Click here to read my ...

Reported EPS is $0.2429 EPS, expectations were $0.63. Operator: Hello, and welcome to the Teva Pharmaceutical Industries ...

In recent health news, WuXi Apptec plans a $980 million share expansion, nursing strikes erupt in Nigeria, Teva ...

The global Cancer Pain Market is valued at USD 6983.5 Million in 2024 and is projected to reach a value of USD 12031.1 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 5.1% between 2025 and ...

On July 16, 2025, Bio-Thera Solutions, Ltd. (“Bio-Thera”) announced that the U.S. Food and Drug Administration (“FDA”) had accepted its ...